Author details

Full Name

BÃ©nÃ©dicte Dubois

Affiliation

ORCID

Career Start Year

1998

Papers

102

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36372866	Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review.	Journal of Neurology	2023
36451354	T1w/FLAIR ratio standardization as a myelin marker in MS patients.	NeuroImage: Clinical	2022
35393342	Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study.	Neurology: Neuroimmunology and NeuroInflammation	2022
35763378	Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis.	European Journal of Neurology	2022
35581971	Neurocysticercosis: An Uncommon Cause of Acute Supratentorial Hydrocephalus.	Journal of the Belgian Society of Radiology	2022
35386698	Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.	Frontiers in Immunology	2022
35366084	Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies.	Journal of Neurology	2022
36618380	Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis.		2022
35035297	The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.	Int J MS Care	2021
33704824	Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis.	Ann Neurol	2021
34122439	Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.	Frontiers in Immunology	2021
33452402	Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients.	Scientific Reports	2021
32666505	Community-acquired bacterial meningitis in adults: emergency department management protocol.	Acta Neurol Belg	2020
31997416	CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity.	Annals of Neurology	2020
30894451	Leveraging human genetics to inform intervention strategies for multiple sclerosis.	Neurology	2019
30541027	A robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune disease.	Human Molecular Genetics	2019
29361022	Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.	Brain	2018
30170791	LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients.	Journal of Neuroimmunology	2018
30332657	Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators.	Cell Reports	2018
29536270	A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.	Acta Neurologica Belgica	2018
29303040	Genetic basis for relapse rate in multiple sclerosis: Association with LRP2 genetic variation.	Multiple Sclerosis Journal	2018
29380254	Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.	Acta Neurologica Belgica	2018
29500681	Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.	Acta Neurologica Belgica	2018
28643598	New insights into the burden and costs of multiple sclerosis in Europe: Results for Belgium.	Multiple Sclerosis Journal	2017
28391390	Corticosteroids in the management of acute multiple sclerosis exacerbations.	Acta Neurologica Belgica	2017
27039700	Power estimation for non-standardized multisite studies.	Neuroimage	2016
27194806	Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.	G3: Genes, Genomes, Genetics	2016
27231713	Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations.	Neurology: Neuroimmunology and NeuroInflammation	2016
25088022	Characteristic callosal involvement in Susac's syndrome.	Acta Neurologica Belgica	2015
25616667	Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.	Brain	2015
25948629	Burden of risk variants correlates with phenotype of multiple sclerosis.	Multiple Sclerosis Journal	2015
26511769	CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.	Nature Communications	2015
26343388	Class II HLA interactions modulate genetic risk for multiple sclerosis.	Nat Genet	2015
24915752	Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.	Acta Neurologica Belgica	2014
24144875	HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.	Multiple Sclerosis Journal	2014
24234648	No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.	Hum Mol Genet	2014
23325590	Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.	Multiple Sclerosis Journal	2013
23870417	Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.	Neurobiol Aging	2013
24076602	Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.	Nat Genet	2013
23880016	Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.	Clinical Neurology and Neurosurgery	2013
23785401	Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.	PLoS One	2013
23483640	No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.	Annals of Neurology	2013
23225573	Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.	Ann Neurol	2013
23730204	Progress in multiple sclerosis genetics.	Current Genomics	2012
22922411	EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.	Nature Medicine	2012
22319148	A trans-specific polymorphism in ZC3HAV1 is maintained by long-standing balancing selection and may confer susceptibility to multiple sclerosis.	Mol Biol Evol	2012
21596847	Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party.	Blood	2011
20603621	Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction.	Bone Marrow Transplantation	2011
21565411	TNFRSF1A coding variants in multiple sclerosis.	Journal of Neuroimmunology	2011
21562247	Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.	Neurology	2011